Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
for Von Hippel-Lindau Disease
Sites in Boston +6 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT07405164·Phase 3·Recruiting·Listed Feb 2026